CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Biological Psychiatry

• Publication date

  2008-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/J.BIOPSYCH.2007.09.003PMID 17950256
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 3,4-methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice.

  2007cited by this paper
• MDMA attenuates THC withdrawal syndrome in mice

  2007cited by this paper
• Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users

  2007cited by this paper
• Chronic cocaine treatment alters dendritic arborization in the adult motor cortex through a CB1 cannabinoid receptor-dependent mechanism.

  2007cited by this paper
• Effects of serotonin 5-HT1B receptor ligands on the cocaine- and food-maintained self-administration in rats.

  2007cited by this paper
• A review of the acute subjective effects of MDMA/ecstasy.

  2006cited by this paper
• Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs

  2006cited by this paper
• Involvement of the endocannabinoid system in drug addiction.

  2006cited by this paper
• Ethanol self-administration and ethanol conditioned place preference are reduced in mice lacking cannabinoid CB1 receptors.

  2005cited by this paper
• A comparison of the reinforcing efficacy of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") with cocaine in rhesus monkeys.

  2005cited by this paper
• 3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system.

  2005cited by this paper
• The endocannabinoid system: a drug discovery perspective.

  2005cited by this paper
• Lack of CB1 Cannabinoid Receptor Impairs Cocaine Self-Administration

  2005cited by this paper
• A reliable model of intravenous MDMA self-administration in naïve mice

  2005cited by this paper
• Time course of opioid and cannabinoid gene transcription alterations induced by repeated administration with fluoxetine in the rat brain.

  2005cited by this paper
• The neural basis of addiction: a pathology of motivation and choice.

  2005cited by this paper
• Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA ("Ecstasy") in rats.

  2004cited by this paper
• Resistance to gemcitabine in a human follicular lymphoma cell line is due to partial deletion of the deoxycytidine kinase gene

  2004cited by this paper
• Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors.

  2004cited by this paper
• Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects

  2004cited by this paper
• Study of the behavioural responses related to the potential addictive properties of MDMA in mice

  2004cited by this paper
• Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the baboon

  2004cited by this paper
• Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects

  2004cited by this paper
• The rewarding properties of MDMA are preserved in mice lacking µ‐opioid receptors

  2004cited by this paper
• Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats

  2003cited by this paper
• The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis.

  2003cited by this paper
• The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

  2003cited by this paper
• Metabolic Mapping of the Effects of Cocaine during the Initial Phases of Self-Administration in the Nonhuman Primate

  2002cited by this paper
• Involvement of CB1 cannabinoid receptors in emotional behaviour

  2002cited by this paper
• Role of the endocannabinoid system in MDMA intracerebral self‐administration in rats

  2002cited by this paper
• 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement

  2002cited by this paper
• Endogenous cannabinoids mediate long-term synaptic depression in the nucleus accumbens

  2002cited by this paper
• Lack of CB1 cannabinoid receptors modifies nicotine behavioural responses, but not nicotine abstinence.

  2002cited by this paper
• Modulation of cannabinoid agonist binding by 5‐HT in the rat cerebellum

  2002cited by this paper
• Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze.

  2002cited by this paper
• The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxiety

  2002cited by this paper
• Control of Serotonergic Function in Medial Prefrontal Cortex by Serotonin-2A Receptors through a Glutamate-Dependent Mechanism

  2001cited by this paper
• (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats.

  2000cited by this paper
• Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice

  2000cited by this paper
• The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain.

  1999cited by this paper
• The effects of cannabinoids on the brain.

  1999cited by this paper
• The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine.

  1999cited by this paper
• Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice.

  1999cited by this paper
• Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors.

  1999cited by this paper
• A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration

  1999cited by this paper
• Dopamine activation of endogenous cannabinoid signaling in dorsal striatum

  1999cited by this paper
• Locomotor response to MDMA is attenuated in knockout mice lacking the 5-HT1B receptor

  1999cited by this paper
• Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors

  1999cited by this paper
• Modulation of Δ9‐tetrahydrocannabinol‐induced hypothermia by fluoxetine in the rat

  1998cited by this paper
• Disruption of the κ‐opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective κ‐agonist U‐50,488H and attenuates morphine withdrawal

  1998cited by this paper
• Modulation of delta9-tetrahydrocannabinol-induced hypothermia by fluoxetine in the rat.

  1998cited by this paper
• Absence of opiate rewarding effects in mice lacking dopamine D2 receptors

  1997cited by this paper
• Carrier‐Mediated Release of Serotonin by 3,4‐Methylenedioxymethamphetamine: Implications for Serotonin‐Dopamine Interactions

  1996cited by this paper
• Methylenedioxymethamphetamine depresses glutamate-evoked neuronal firing and increases extracellular levels of dopamine and serotonin in the nucleus accumbens in vivo.

  1994cited by this paper
• Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

  1991cited by this paper
• Ecstasy, 3–4 Methylenedioxymethamphetamine (MDMA), a Fatality Associated with Coagulopathy and Hyperthermia

  1991cited by this paper
• Methylenedioxymethamphetamine's capacity to establish place preferences and modify intake of an alcoholic beverage.

  1990cited by this paper
• Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.

  1989cited by this paper
• Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.

  1988cited by this paper
• Self-administration of methylenedioxymethamphetamine (MDMA) by rhesus monkeys.

  1986cited by this paper

• The nucleus accumbens in reward and aversion processing: insights and implications

  2024cites this paper
• Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents.

  2024cites this paper
• Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment

  2022cites this paper
• Cannabinoid type 1 receptors in A2a neurons contribute to cocaine-environment association

  2021cites this paper
• Cannabidiol Modulates the Motivational and Anxiety-Like Effects of 3,4-Methylenedioxypyrovalerone (MDPV) in Mice

  2021cites this paper
• Of mice and men on MDMA: a translational comparison of the neuropsychobiological effects of 3,4-methylenedioxymethamphetamine ('Ecstasy').

  2019cites this paper
• Role of the endocannabinoid system in drug addiction.

  2018cites this paper
• Cannabis and the Use of Amphetamine-Like Substances

  2017cites this paper
• Neurochemical substrates of the rewarding effects of MDMA: implications for the development of pharmacotherapies to MDMA dependence

  2016influential citation
• Prevention of drug priming- and cue-induced reinstatement of MDMA-seeking behaviors by the CB1 cannabinoid receptor antagonist AM251.

  2016cites this paper
• CHAPTER 12 Cannabinoids and drugaddiction

  2016influential citation
• Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction?

  2016influential citation
• Cannabinoids and drug addiction

  2015cites this paper
• Genetic Manipulation of the Endocannabinoid System.

  2015cites this paper
• The novelty-seeking phenotype modulates the long-lasting effects of adolescent MDMA exposure.

  2015cites this paper
• Quantitative Arbor Analytics: Unsupervised Harmonic Co-Clustering of Populations of Brain Cell Arbors Based on L-Measure

  2014cites this paper
• Acute Co-Administration of the Cannabinoid Receptor Agonist WIN 55- 212,2 does not Influence 3,4-Methylenedioxymetamphetamine (MDMA)- Induced Effects on Effort-Based Decision Making, Locomotion, Food Intake and Body Temperature

  2014cites this paper
• Chronic co-administration of the cannabinoid receptor agonist WIN55,212-2 during puberty or adulthood reverses 3,4 methylenedioxymetamphetamine (MDMA)-induced deficits in recognition memory but not in effort-based decision making.

  2013cites this paper
• 50 years of hurdles and hope in anxiolytic drug discovery

  2013cites this paper
• Inhibition of FAAH and activation of PPAR: new approaches to the treatment of cognitive dysfunction and drug addiction.

  2013influential citation
• Endocannabinoid system and drug addiction: new insights from mutant mice approaches.

  2013cites this paper
• Influence of chronic caffeine on MDMA-induced behavioral and neuroinflammatory response in mice

  2013cites this paper
• Neurochemical substrates of MDMA reward: effects of the inhibition of serotonin reuptake on the acquisition and reinstatement of MDMA-induced CPP.

  2013cites this paper
• Modulation of 3,4-methylenedioxymethamphetamine effects by endocannabinoid system.

  2013cites this paper
• Assessment of the abuse potential of MDMA in the conditioned place preference paradigm: role of CB1 receptors.

  2013cites this paper
• Drug withdrawal-induced depression: serotonergic and plasticity changes in animal models.

  2012cites this paper
• The orphan receptor GPR3 modulates the early phases of cocaine reinforcement

  2012cites this paper
• EFFECTS OF ACUTE AND CHRONIC TREATMENT WITH 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) AND THE CANNABINOID RECEPTOR AGONIST WIN55,212-2 ON BEHAVIOUR AND COGNITION IN RATS

  2012cites this paper
• MDMA: interactions with other psychoactive drugs.

  2011cites this paper
• Acute blockade of CB1 receptor leads to reinstatement of MDMA-induced conditioned place preference.

  2011cites this paper
• A single episode of maternal deprivation impairs the motivation for cocaine in adolescent mice

  2011cites this paper
• The A2a adenosine receptor modulates the reinforcement efficacy and neurotoxicity of MDMA

  2011cites this paper
• Behavioural and neuroinflammatory effects of the combination of binge ethanol and MDMA in mice

  2011cites this paper
• The ugly side of amphetamines: short- and long-term toxicity of 3,4-methylenedioxymethamphetamine (MDMA, ‘Ecstasy’), methamphetamine and d-amphetamine

  2011cites this paper
• Effects of MDMA ("ecstasy") during adolescence on place conditioning and hippocampal neurogenesis.

  2010cites this paper
• THC Prevents MDMA Neurotoxicity in Mice

  2010cites this paper
• Cannabinoids, opioids and MDMA: neuropsychological interactions related to addiction.

  2010cites this paper
• Synthesis of Fatty Acid Amides of Catechol Metabolites that Exhibit Antiobesity Properties

  2010cites this paper
• A Cannabinoid CB1 Receptor Antagonist Ameliorates Impairment of Recognition Memory on Withdrawal from MDMA (Ecstasy)

  2010cites this paper
• Mice in ecstasy: advanced animal models in the study of MDMA.

  2010cites this paper
• Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice

  2010cites this paper
• MDMA Self-Administration in Laboratory Animals: A Summary of the Literature and Proposal for Future Research

  2009cites this paper
• Interactions between the anxiogenic effects of CB1 gene disruption and 5-HT3 neurotransmission

  2009influential citation
• Molecular and Cellular Mechanisms of Ecstasy-Induced Neurotoxicity: An Overview

  2009cites this paper
• Efectos conductuales y neuroquímicos del consumo de éxtasis y cocaína en ratones adolescentes.

  2009cites this paper
• Study of the interaction between 3,4 methylenedioximethamphetamine and the endocannabinoid system

  2009cites this paper